Brooks Laboratories (BOM:533543) 3-Year Revenue Growth Rate : 0.30% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Brooks Laboratories 3-Year Revenue Growth Rate?

Brooks Laboratories's Revenue per Share for the three months ended in Mar. 2024 was ₹6.99.

During the past 12 months, Brooks Laboratories's average Revenue per Share Growth Rate was 22.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 0.30% per year. During the past 5 years, the average Revenue per Share Growth Rate was -1.40% per year. During the past 10 years, the average Revenue per Share Growth Rate was -3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Brooks Laboratories was 23.10% per year. The lowest was -41.60% per year. And the median was 0.30% per year.

Competitive Comparison of Brooks Laboratories's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Brooks Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brooks Laboratories's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Brooks Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Brooks Laboratories's 3-Year Revenue Growth Rate falls into.

Brooks Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Brooks Laboratories (BOM:533543) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Brooks Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Brooks Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Brooks Laboratories (BOM:533543) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Brooks Laboratories Ltd (BOM:533543) » Definitions » 3-Year Revenue Growth Rate

Traded in Other Exchanges

BROOKS:India

Address

Off. Andheri Kurla Road, 201, The Summit Business Park, Behind Guru Nanak Petrol Pump, Andheri (East), Mumbai, MH, IND, 400 093

Website

https://www.brookslabs.net

Brooks Laboratories Ltd is an Indian company operating in the healthcare sector. The company is engaged in the formulation, development, production, and export of drugs and pharmaceuticals. It has manufacturing sites located in Baddi, Himachal Pradesh, and Vadodara, Gujarat. It manufactures drugs in a variety of forms, including tablets, dry syrup, injections, liquid injections, dry powder injections, eye drops, and ear drops. Its products include carbapenem and penicillins.

Brooks Laboratories (BOM:533543) Headlines

No Headlines